SITC 2021

November 10–14, 2021, Hybrid

Amgen is proud to be a part of the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021). While you’re here, you can explore the latest scientific information and disease state education. Additionally, you can learn about Amgen’s long-term commitment to developing and delivering transformative medicines for oncology patients.

Amgen | A Worldwide Pioneer in Biotechnology

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit and follow us on